Treatment for hypertension, male in Algeria
Algeria: Treatment for hypertension, male was 30.1% in 2019. ▲ Rising
Treatment for hypertension, male in Algeria, 1990–2019
Source: World Health Organization's Global Health Observatory Data Repository. Measured in % of male adults ages 30-79 with hypertension.
Analysis
In 2019, treatment for hypertension, male in Algeria stood at 30.1%. That is the highest value across all 30 years on record.
Compared with earlier readings it is up 0.3% on the previous year and up 17.1% over ten years.
Over the whole period, treatment for hypertension, male in Algeria peaked at 30.1% in 2019 and was at its lowest, 12.9%, in 1990.
That places Algeria 113th out of 192 countries with data for 2019, putting it in the middle of the range.
The long-run direction has been consistently rising across the 30 years of available data.
Treatment for hypertension, male in Algeria, year by year
| Year | % of male adults ages 30-79 with hypertension | Change |
|---|---|---|
| 1990 | 12.9% | — |
| 1991 | 13.3% | +3.1% |
| 1992 | 13.6% | +2.3% |
| 1993 | 14.0% | +2.9% |
| 1994 | 14.5% | +3.6% |
| 1995 | 14.9% | +2.8% |
| 1996 | 15.4% | +3.4% |
| 1997 | 16.0% | +3.9% |
| 1998 | 16.5% | +3.1% |
| 1999 | 17.2% | +4.2% |
| 2000 | 17.9% | +4.1% |
| 2001 | 18.6% | +3.9% |
| 2002 | 19.4% | +4.3% |
| 2003 | 20.3% | +4.6% |
| 2004 | 21.2% | +4.4% |
| 2005 | 22.1% | +4.2% |
| 2006 | 23.1% | +4.5% |
| 2007 | 24.0% | +3.9% |
| 2008 | 24.9% | +3.7% |
| 2009 | 25.7% | +3.2% |
| 2010 | 26.5% | +3.1% |
| 2011 | 27.2% | +2.6% |
| 2012 | 27.9% | +2.6% |
| 2013 | 28.4% | +1.8% |
| 2014 | 28.9% | +1.8% |
| 2015 | 29.3% | +1.4% |
| 2016 | 29.6% | +1.0% |
| 2017 | 29.8% | +0.7% |
| 2018 | 30.0% | +0.7% |
| 2019 | 30.1% | +0.3% |
Algeria compared with similar countries
- Algeria's 30.1% is below the median for upper middle income countries, which is 35.6%, 84% of the median. (58 countries reporting)
- Algeria's 30.1% is below the median for Middle East, North Africa, Afghanistan & Pakistan, which is 37.0%, 81% of the median. (23 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 14.8% | 12.9% | 17.2% | 10 |
| 2000s | 21.7% | 17.9% | 25.7% | 10 |
| 2010s | 28.8% | 26.5% | 30.1% | 10 |
Countries ranked near Algeria
More health data for Algeria
- Un projection of annual infant deaths, annual growth rate -1.82 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.5437 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 943.1 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1,455 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.77 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0465 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.77 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is treatment for hypertension, male in Algeria?
- Treatment for hypertension, male in Algeria was 30.1% in 2019, according to World Health Organization's Global Health Observatory Data Repository.
- What is the highest treatment for hypertension, male recorded in Algeria?
- The highest recorded value was 30.1% in 2019.
- What is the lowest treatment for hypertension, male recorded in Algeria?
- The lowest recorded value was 12.9% in 1990.
- How does Algeria rank for treatment for hypertension, male?
- Algeria ranks 113th out of 192 countries with data for 2019.
- Is treatment for hypertension, male rising or falling in Algeria?
- Over the last ten years it is up 17.1%. The long-run trend across the full record is rising.
- Where does this Algeria data come from?
- The figures come from World Health Organization's Global Health Observatory Data Repository, published as part of Treatment for hypertension, male (% of male adults ages 30-79 with hypertension). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 30 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Treatment for hypertension, male, is the percentage of adults ages 30-79 with hypertension who were taking medicine for hypertension. Hypertension is defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension.